{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:16:31Z","timestamp":1790496991865,"version":"4.1.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0130612","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T18:14:28Z","timestamp":1435169668000},"page":"e0130612","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-\u03b2 (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis"],"prefix":"10.1371","volume":"10","author":[{"given":"Caroline J.","family":"Aalbers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette","family":"Bevaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Loiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"de Cortie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Fraser","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mingozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul P.","family":"Tak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margriet J.","family":"Vervoordeldonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.2741\/1475","article-title":"IFN-beta in rheumatoid arthritis","volume":"9","author":"PP Tak","year":"2004","journal-title":"Front Biosci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"R239","DOI":"10.1186\/ar1165","article-title":"Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis","volume":"6","author":"J Van Holten","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/1529-0131(199901)42:1<90::AID-ANR12>3.0.CO;2-A","article-title":"Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy","volume":"42","author":"KA Triantaphyllopoulos","year":"1999","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/rheumatology\/38.4.362","article-title":"The effects of interferon beta treatment on arthritis","volume":"38","author":"PP Tak","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.2003.020347","article-title":"A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis","volume":"64","author":"J Van Holten","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1089\/hum.2006.17.985","article-title":"Intraarticular interferon-beta gene therapy ameliorates adjuvant arthritis in rats","volume":"17","author":"J Adriaansen","year":"2006","journal-title":"Hum Gene Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1073\/pnas.92.12.5719","article-title":"DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors","volume":"92","author":"DW Russell","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/ard.2004.035063","article-title":"Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy","volume":"64","author":"J Adriaansen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1089\/hum.2005.16.426","article-title":"Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints","volume":"16","author":"F Apparailly","year":"2005","journal-title":"Hum Gene Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors","volume":"21","author":"S Boutin","year":"2010","journal-title":"Hum Gene Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/gt.2012.55","article-title":"Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue","volume":"20","author":"F Mingozzi","year":"2013","journal-title":"Gene Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1099\/vir.0.82603-0","article-title":"Local delivery of beta interferon using an adeno-associated virus type 5 effectively inhibits adjuvant arthritis in rats","volume":"88","author":"J Adriaansen","year":"2007","journal-title":"J Gen Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1182\/blood-2006-03-010181","article-title":"Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates","volume":"109","author":"AC Nathwani","year":"2007","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1089\/hum.2009.031","article-title":"Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders","volume":"20","author":"A Paneda","year":"2009","journal-title":"Hum Gene Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1089\/hum.2010.155","article-title":"Safety of liver gene transfer following peripheral intravascular delivery of adeno-associated virus (AAV)-5 and AAV-6 in a large animal model","volume":"22","author":"P Favaro","year":"2011","journal-title":"Hum Gene Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/sj.gt.3300680","article-title":"Adeno-associated virus vectors can be efficiently produced without helper virus","volume":"5","author":"T Matsushita","year":"1998","journal-title":"Gene Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"GP Gao","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/ard.2010.139550","article-title":"Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials","volume":"70","author":"MG van de Sande","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4","article-title":"Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation","volume":"44","author":"PP Tak","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"2","key":"ref20","first-page":"1742","article-title":"Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology","volume":"3","author":"JM Ruijter","year":"2006","journal-title":"Retrovirology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1566523054065057","article-title":"New recombinant serotypes of AAV vectors","volume":"5","author":"G Gao","year":"2005","journal-title":"Curr Gene Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/JVI.78.6.2863-2874.2004","article-title":"Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia","volume":"78","author":"Z Yan","year":"2004","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/hum.2006.128","article-title":"Hybrid adeno-associated virus bearing nonhomologous inverted terminal repeats enhances dual-vector reconstruction of minigenes in vivo","volume":"18","author":"Z Yan","year":"2007","journal-title":"Hum Gene Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.neuint.2009.05.005","article-title":"Doxorubicin augments rAAV-2 transduction in rat neuronal cells","volume":"55","author":"T Zhang","year":"2009","journal-title":"Neurochem Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1128\/JVI.68.12.8282-8287.1994","article-title":"DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors","volume":"68","author":"IE Alexander","year":"1994","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/art.20278","article-title":"Toward a better understanding of methotrexate","volume":"50","author":"JM Kremer","year":"2004","journal-title":"Arthritis Rheum"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/art.1780371210","article-title":"Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients","volume":"37","author":"C Bologna","year":"1994","journal-title":"Arthritis Rheum"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/art.27503","article-title":"Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis?","volume":"62","author":"L Bevaart","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.4049\/jimmunol.163.4.2202","article-title":"Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees","volume":"163","author":"ER Lechman","year":"1999","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/sj.gt.3302109","article-title":"The contralateral effect conferred by intra-articular adenovirus-mediated gene transfer of viral IL-10 is specific to the immunizing antigen","volume":"10","author":"ER Lechman","year":"2003","journal-title":"Gene Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm.2050","article-title":"Synovial fibroblasts spread rheumatoid arthritis to unaffected joints","volume":"15","author":"S Lefevre","year":"2009","journal-title":"Nat Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1073\/pnas.0502854102","article-title":"Gene transfer to human joints: progress toward a gene therapy of arthritis","volume":"102","author":"CH Evans","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/sj.mt.6300151","article-title":"Transgene persistence and cell turnover in the diarthrodial joint: implications for gene therapy of chronic joint diseases","volume":"15","author":"E Gouze","year":"2007","journal-title":"Mol Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/gt.2012.81","article-title":"scAAV-mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian joints","volume":"20","author":"RS Watson","year":"2013","journal-title":"Gene Ther"},{"issue":"Suppl 1","key":"ref35","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1478-6354-13-S1-S5","article-title":"Advances in rheumatology: new targeted therapeutics","volume":"13","author":"PP Tak","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1\u20139 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"C Zincarelli","year":"2008","journal-title":"Mol Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood-2008-10-181479","article-title":"Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy","volume":"113","author":"GP Niemeyer","year":"2009","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/mt.2010.274","article-title":"Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins","volume":"19","author":"AC Nathwani","year":"2011","journal-title":"Mol Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0130612","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T19:27:42Z","timestamp":1691782062000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0130612"}},"subtitle":[],"editor":[{"given":"R. Jude","family":"Samulski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,24]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0130612","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,24]]}}}